 BEVERLY, Mass., June 10, 2021 GLOBE NEWSWIRE -- LexaGene Holdings, Inc., OTCQB: LXXGF; TSX-V: LXG a molecular diagnostics company that develops fully automated, rapid pathogen detection systems, today announced it has successfully utilized the MiQLabTM System to detect the presence of a slow growing bacterium, responsible for millions of dollars of damages to biopharmaceutical manufacturers. 